Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo-Reference-Cited by-同舟云学术

Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo

Published:2019-03-15 Issue:4 Volume:30 Page:1244-1257
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Francini Nora¹,Cochrane Daniel²,Illingworth Sam²,Purdie Laura¹,Mantovani Giuseppe¹^ORCID,Fisher Kerry²³,Seymour Leonard W.³,Spain Sebastian G.⁴^ORCID,Alexander Cameron¹

Affiliation:

1. School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.

2. PsiOxus Therapeutics Limited, 4-10, The Quadrant, Abingdon Science Park, Abingdon, Oxfordshire OX14 3YS, U.K.

3. Department of Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.

4. Department of Chemistry, University of Sheffield, Sheffield S3 7HF, U.K.

Funder

Engineering and Physical Sciences Research Council

Royal Society

PsiOxus Therapeutics

Publisher

American Chemical Society (ACS)

Subject